Carl Regillo

4PUBLICATIONS
11CO-AUTHORS
Vision scienceGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jul 28, 2026
Real-World Safety of Intravitreal Complement Inhibitor Avacincaptad Pegol for Geographic Atrophy.

|Dec 18, 2025
TALON phase IIIb study: 64 week results of brolucizumab versus aflibercept using treat-and-extend for neovascular age-related macular degeneration.

Carl Regillo, Peter K Kaiser, Peter J Kertes

Pageof 1

Frequent Collaborators

2 joint publications

Ashish Sharma

1 joint publications

Peter K Kaiser

1 joint publications

Peter J Kertes

1 joint publications

Mark Gillies